Toxic epidermal necrolysis associated with nivolumab treatment for head and neck cancer

This report is the first to document TEN caused by nivolumab treatment in head and neck cancer. We believe this article can contribute significantly in understanding the principles of nivolumab treatment in patients with head and neck cancer.

Detalles Bibliográficos
Autores principales: Koshizuka, Keiichi, Sakurai, Daiju, Sunagane, Miki, Mita, Yukiyoshi, Hamasaki, Sawako, Suzuki, Takeshi, Kikkawa, Naoko, Nakano, Michiyo, Hanazawa, Toyoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869372/
https://www.ncbi.nlm.nih.gov/pubmed/33598257
http://dx.doi.org/10.1002/ccr3.3695
Descripción
Sumario:This report is the first to document TEN caused by nivolumab treatment in head and neck cancer. We believe this article can contribute significantly in understanding the principles of nivolumab treatment in patients with head and neck cancer.

Ejemplares similares